@article{WirthensohnWehrliLjungbladetal.2023,
  author    = {Miriam Wirthensohn and Susanne Wehrli and Ulf Wike Ljungblad and Martina Huemer},
  title     = {Biochemical, nutritional, and clinical parameters of vitamin B12 deficiency in infants},
  series   = {Nutrients},
  volume    = {15},
  issn      = {2072-6643},
  doi       = {10.3390/nu15234960},
  year      = {2023},
  abstract  = {Pooled data from published reports on infants with clinically diagnosed vitamin B12 (B12) deficiency were analyzed with the purpose of describing the presentation, diagnostic approaches, and risk factors for the condition to inform prevention strategies. An electronic (PubMed database) and manual literature search following the PRISMA approach was conducted (preregistration with the Open Science Framework, accessed on 15 February 2023). Data were described and analyzed using correlation analyses, Chi-square tests, ANOVAs, and regression analyses, and 102 publications (292 cases) were analyzed. The mean age at first symptoms (anemia, various neurological symptoms) was four months; the mean time to diagnosis was 2.6 months. Maternal B12 at diagnosis, exclusive breastfeeding, and a maternal diet low in B12 predicted infant B12, methylmalonic acid, and total homocysteine. Infant B12 deficiency is still not easily diagnosed. Methylmalonic acid and total homocysteine are useful diagnostic parameters in addition to B12 levels. Since maternal B12 status predicts infant B12 status, it would probably be advantageous to target women in early pregnancy or even preconceptionally to prevent infant B12 deficiency, rather than to rely on newborn screening that often does not reliably identify high-risk children.},
  language  = {en}
}